case_images: PMC10591075_01
case_images: Before dupilumab therapy.
case_images: fmed-10-1253795-g0001.jpg
case_images: PMC10591075_01_fmed-10-1253795-g0001.jpg
case_images: F1
case_images: During the 6 months of treatment with baricitinib, the patient's condition did not improve (Figure 1).
case_images: After 3 months of dupilumab therapy.
case_images: fmed-10-1253795-g0002.jpg
case_images: PMC10591075_01_fmed-10-1253795-g0002.jpg
case_images: F2
case_images: The pull test result was negative, and the SALT score was 58 (percentage improvement of SALT = 58%), with little hair regrowth in the eyebrows and eyelashes (Figure 2).
case_images: After 10 months of dupilumab therapy.
case_images: fmed-10-1253795-g0003.jpg
case_images: PMC10591075_01_fmed-10-1253795-g0003.jpg
case_images: F3
case_images: After 10 months of treatment, the SALT score was 85 (percentage improvement of SALT = 85%) (Figure 3).